A retrospective analysis of Vulva Carcinoma patients treated at a cancer center in Nepal in ten years

Sarita Rana; Bijay  Chandra Acharya; Aditya Jalan; Manju Pandey; Hemnath  Subedi; Ishan Dhungana; Nirmal Lamichhane; Binuma  Shrestha

doi:10.46405/ejms.v3i2.381

Sarita Rana BP Koirala Memorial Cancer Hospital https://orcid.org/0000-0003-1620-2355
Bijay Chandra Acharya B P Koirala Memorial Cancer Hospital, Nepal
Aditya Jalan B P Koirala Memorial Cancer Hospital, Nepal https://orcid.org/0000-0002-6509-3581
Manju Pandey B P Koirala Memorial Cancer Hospital, Nepal https://orcid.org/0000-0001-6962-2420
Hemnath Subedi B P Koirala Memorial Cancer Hospital, Nepal https://orcid.org/0000-0002-3563-5263
Ishan Dhungana B P Koirala Memorial Cancer Hospital, Nepal
Nirmal Lamichhane B P Koirala Memorial Cancer Hospital, Nepal https://orcid.org/0000-0003-0667-6434
Binuma Shrestha B P Koirala Memorial Cancer Hospital, Nepal

DOI: https://doi.org/10.46405/ejms.v3i2.381

Keywords: Vulval cancer, lymph node dissection, smoking, recurrence, squamous cell

Abstract

Introduction:

Vulvar cancer is not an uncommon condition, accounting for 4-6% of all female genital tract cancers. More than ninety percent of cancers are squamous cell type. In this study, we have attempted to retrospectively analyze the socio-demographic profile of vulvar cancer patients managed at BP Koirala Memorial Cancer Hospital.

Material and methods:

This is a descriptive cross-sectional study, that altogether included 77 patients from January 2009 to December 2019 diagnosed with vulvar cancer conducted at BP Koirala Memorial Cancer Hospital, Nepal. All the demographic and clinicopathological data were collected and analyzed using SPSS 16.0 software. Tumor staging was standardized according to the International Federation of Gynecology and Obstetrics (FIGO) staging system. Quantitative data were represented as mean and standard deviation whereas categorical variables were expressed as frequencies and percentages of an appropriate denominator.

Results:

Among 77 patients, the median age was 55 years. Most were married (97.4%, n=75), farmers (53.2% n=41), smokers (45.45%, n=35), had poor personal hygiene (65.6%, n=50) and illitrate (61%, n=47). The most common presentation was ulcer or growth (88.31%, n=68). Inguinal lymph nodes were palpable in 80.5% (n=62) of patients, out of which 26% (n=20) had fixed and fungating lymph nodes. Most diagnosed clinical was stage III (40.25%, n=31), stage IV (27%, n=21), stage II (19.48%, n=15) and Stage I (13%, n =10). The most common histological grading was moderately differentiated SCC (50.6%, n=39). Management was surgical in 72.72% (n=56) and rest 27.27%(n=21) were sent for chemoradiation. The most common postoperative complications were lymphedema (27%, n= 15) and wound infections (12.5%, n=7). Recurrence observed in 28.57% (n=22) of cases.

Conclusion:

Vulvar cancer is more common among smokers and farmers. The disease is already locally advanced at the time of diagnosis. However, surgery is the main modality of treatment.

References

1. Pariyar J, Shrestha B, Acharya B, Jha A,Shrestha S, Shrestha J,Shrestha S. Carcinoma of Vulva in Nepalese Women Managed at B. P. Koirala Memorial Cancer Hospita. Nep Jol Info. Vol 3 No 1: 3-38. 2019. https://doi.org/10.3126/njc.v3i1.25913 [Google scholar] [Full Text]
2. Lee LJ, Howitt B, Catalano P, Tanaka C, Murphy R, Cimbak N, et al. Prognostic importance of human papillomavirus (HPV) and p16 positivity in squamous cell carcinoma of the vulva treated with radiotherapy. Gynecol Oncol. 2016;142(2):293-8. https://doi.org/10.1016/j.ygyno.2016.05.019 [Google scholar] [PubMed]
3. Amavi AK, Kouadio L, Adabra K, Tengue K, Tijami F, Jalil A. Surgical management for squamous cell carcinoma of vulva. Pan Afr Med J. 2016;24:145. https://doi.org/10.11604/pamj.2016.24.145.8485 [Google scholar] [PubMed]
4. Meelapkij P, Suprasert P, Baisai O. Treatment Outcomes of Patients with Squamous Cell Carcinoma of the Vulva: The Largest Series from a Tertiary Care Hospital. Obstet Gynecol Int. 2018;2018:4723167. https://doi.org/10.1155/2018/4723167 [Google scholar] [PubMed]
5. Hussain SK, Madeleine MM, Johnson LG, Du Q, Malkki M, Wilkerson HW, et al. Cervical and vulvar cancer risk in relation to the joint effects of cigarette smoking and genetic variation in interleukin 2. Cancer Epidemiol Biomarkers Prev. 2008;17(7):1790-9. https://doi.org/10.1158/1055-9965.EPI-07-2753 [Google scholar] [PubMed] [Full Text]
6. Sharma DN, Rath GK, Kumar S, Bhatla N, Julka PK, Sahai P. Treatment outcome of patients with carcinoma of vulva: experience from a tertiary cancer center of India. J Cancer Res Ther. 2010;6(4):503-7. https://doi.org/10.4103/0973-1482.77090 [Google scholar] [PubMed]
7. Bogani G, Cromi A, Serati M, Uccella S, Donato VD, Casarin J, et al. Predictors and Patterns of Local, Regional, and Distant Failure in Squamous Cell Carcinoma of the Vulva. Am J Clin Oncol. 2017;40(3):235-40. https://doi.org/10.1097/COC.00000000000001388 [Google Scholar] [PubMed]
8. Rao YJ, Chin RI, Hui C, Mutch DG, Powell MA, Schwarz JK, et al. Improved survival with definitive chemoradiation compared to definitive radiation alone in squamous cell carcinoma of the vulva: A review of the National Cancer Database. Gynecol Oncol. 2017;146(3):572-9. https://doi.org/10.1016/j.ygyno.2017.06.022
[Google scholar] [PubMed]
9. Hinten F, van den Einden LC, Cissen M, IntHout J, Massuger LF, de Hullu JA. Clitoral involvement of squamous cell carcinoma of the vulva: localization with the worst prognosis. Eur J Surg Oncol. 2015;41(4):592-8. https://doi.org/10.1016/j.ejso.2015.01.002 [Google scholar] [PubMed]
10. Le T, Elsugi R, Hopkins L, Faught W, Fung-Kee-Fung M. The definition of optimal inguinal femoral nodal dissection in the management of vulva squamous cell carcinoma. Ann Surg Oncol. 2007;14(7):2128-32. https://doi.org/10.1245/s10434-007-9417-5] [Google scholar] [PubMed]
11. Stehman FB, Look KY. Carcinoma of the vulva. Obstet Gynecol. 2006;107(3):719-33. https://doi.org/10.1097/01.AOG.0000202404.55215.72 [Google scholar] [PubMed]
12. Rogers LJ, Howard B, Van Wijk L, Wei W, Dehaeck K, Soeters R, et al. Chemoradiation in advanced vulval carcinoma. Int J Gynecol Cancer. 2009;19(4):745-51. https://doi.org/10.1111/IGC.0b013e3181a13021 [Google scholar] [PubMed]
13. Raspagliesi F, Zanaboni F, Martinelli F, Scasso S, Laufer J, Ditto A. Role of paclitaxel and cisplatin as the neoadjuvant treatment for locally advanced squamous cell carcinoma of the vulva. J Gynecol Oncol. 2014;25(1):22-9. https://doi.org/10.3802/jgo.2014.25.1.22 [Google scholar] [PubMed]